Australian company BiVACOR has successfully implanted its Total Artificial Heart (TAH) in a patient who survived for 100 days while waiting for a donor heart. The TAH utilizes a unique design with only one moving part, a magnetically levitated rotor, allowing efficient blood circulation and minimizing wear compared to previous models. This innovative device aims to provide a temporary solution for patients with heart disorders while they await transplants. BiVACOR's goal is to enhance the TAH’s durability to match the life span of a natural heart, addressing the critical shortage of available donor organs.
BiVACOR's Total Artificial Heart, featuring a single moving part, successfully sustained a patient for over 100 days before he received a transplant.
The TAH uses magnetic levitation for its rotor to minimize wear and failure, addressing a significant issue with previous artificial heart designs.
Collection
[
|
...
]